Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCellectar Biosciences, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Cellectar Biosciences, Inc.

$1.40Close · Oct 8, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
$
2025201720182019202020212022202320242025-40M-30M-20M-10M0
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    Latest period 2025. Operating cash flow -23.1M. Capex -5.9K. Free cash flow -23.1M.
    Operating cash flowCapexFree cash flow
    Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
    2026201720182019202020212022202320242025010M20M30M40M50M
        Latest period 2026. Cash 34M. Debt 0.
        CashDebtNet cash
        Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
        $/share
        2025201720182019202020212022202320242025-25,000.00-20,000.00-15,000.00-10,000.00-5,000.000.00
          • Earnings period 2017-01-01 to 2017-12-31. Shares as of 2017-12-31: 1,666,144 source shares.
          • Earnings period 2018-01-01 to 2018-12-31. Shares as of 2018-12-31: 4,732,387 source shares.
          • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2019-12-31: 9,386,689 source shares.
          • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 45,442,729 source shares.
          • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 6,110,125 source shares.
          • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 9,385,272 source shares.
          • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 20,744,110 source shares.
          • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 1,535,996 source shares.
          • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 4,240,129 source shares.
          Latest period FY 2025. EPS (TTM) -5.14.
          EPS (TTM)
          How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
          2025201720182019202020212022202320242025-6x-4x-2x0x
            • Earnings period 2017-01-01 to 2017-12-31. Shares as of 2017-12-31: 1,666,144 source shares. Nearby weekly price on 2017-12-29.
            • Earnings period 2018-01-01 to 2018-12-31. Shares as of 2018-12-31: 4,732,387 source shares. Nearby weekly price on 2018-12-28.
            • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2019-12-31: 9,386,689 source shares. Nearby weekly price on 2020-01-03.
            • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2020-12-31: 45,442,729 source shares. Weekly price on 2020-12-31.
            • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 6,110,125 source shares. Weekly price on 2021-12-31.
            • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 9,385,272 source shares. Nearby weekly price on 2022-12-30.
            • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 20,744,110 source shares. Nearby weekly price on 2023-12-29.
            • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 1,535,996 source shares. Nearby weekly price on 2025-01-03.
            • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 4,240,129 source shares. Nearby weekly price on 2026-01-02.
            Latest period FY 2025. P/E ratio -0.7x.
            P/E ratio
            See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
            2026201720182019202020212022202320242025020M40M60M
            2018-07-17: Reverse stock split 1-for-10
            2022-07-22: Reverse stock split 1-for-10
            2025-06-24: Reverse stock split 1-for-30
                Latest period 2026. Shares outstanding 8.3M. Class detail unavailable 8.3M.
                Class detail unavailableStock split